While these relationships reflect systemic insulin resistance, it is critical to note that brain tissue itself is insulin resistant in AD in subjects who, at the time of death, were without other co-morbidities that feature insulin resistance, such as DM2, obesity or the metabolic syndrome. Here, INS is linked to myotonic dystrophy type 2.